These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1459828)
21. Terodiline in the treatment of children with unstable bladders. Hellström AL; Hjälmås K; Jodal U Br J Urol; 1989 Apr; 63(4):358-62. PubMed ID: 2653554 [TBL] [Abstract][Full Text] [Related]
22. Effects of terodiline on urinary incontinence among older non-institutionalized women. Terodiline in the Elderly American Multicenter Study Group. J Am Geriatr Soc; 1993 Sep; 41(9):915-22. PubMed ID: 8409177 [TBL] [Abstract][Full Text] [Related]
23. [Clinical effects of terodiline hydrochloride for urinary frequency and sense of residual urine]. Fujiwara E; Nakano H; Nihira H; Kitano T; Ukai R; Masu C; Onishi Y; Kodama M; Hatachi K; Matsuki A Hinyokika Kiyo; 1988 Apr; 34(4):733-8. PubMed ID: 3400553 [TBL] [Abstract][Full Text] [Related]
24. Terodiline and oxybutynin in detrusor instability. Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752 [No Abstract] [Full Text] [Related]
25. [Treatment of the unstable bladder in children with the anticholinergic agent propiverin hydrochloride (mictonorm/mictonets)]. Otto-Unger G Z Urol Nephrol; 1985 Mar; 78(3):145-52. PubMed ID: 4002894 [TBL] [Abstract][Full Text] [Related]
26. The effects of terodiline and meladrazine on severe motor urge incontinence in geriatric patients. Beisland HO; Fossberg E J Am Geriatr Soc; 1985 Jan; 33(1):29-32. PubMed ID: 3880780 [TBL] [Abstract][Full Text] [Related]
27. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial. Petersen T; Jakobsen J J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1331-6. PubMed ID: 3681312 [TBL] [Abstract][Full Text] [Related]
28. Enuresis: principles of management and result of treatment. Kass EJ; Diokno AC; Montealegre A J Urol; 1979 Jun; 121(6):794-6. PubMed ID: 458953 [TBL] [Abstract][Full Text] [Related]
29. Intravesical instillation of terodiline--an in vivo study of drug absorption in rabbit and man. Ekström B; Larsson B; Andersson KE; Mattiasson A J Urol; 1993 Dec; 150(6):1926-31. PubMed ID: 8230539 [TBL] [Abstract][Full Text] [Related]
30. [Primary enuresis: urodynamic evaluation for prognostic and therapeutic purposes]. Conejero Sugrañes J; Idoipe Tomás JI; Alcover García J; Zamora P Actas Urol Esp; 1980; 4(6):311-4. PubMed ID: 7468361 [No Abstract] [Full Text] [Related]
31. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood. Yucel S; Kutlu O; Kukul E; Baykara M Urology; 2004 Nov; 64(5):1020-5; discussion 1025. PubMed ID: 15533498 [TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. Schulman SL; Stokes A; Salzman PM J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804 [TBL] [Abstract][Full Text] [Related]
33. Ultrasound bladder measurements in patients with primary nocturnal enuresis: a urodynamic and treatment outcome correlation. Yeung CK; Sreedhar B; Leung VT; Metreweli C J Urol; 2004 Jun; 171(6 Pt 2):2589-94. PubMed ID: 15118426 [TBL] [Abstract][Full Text] [Related]
34. The effect of terodiline treatment in women with motor urge incontinence. Results from a double-blind study and long-term treatment. Ulmsten U; Ekman G; Andersson KE Am J Obstet Gynecol; 1985 Nov; 153(6):619-22. PubMed ID: 2998191 [TBL] [Abstract][Full Text] [Related]
35. [Clinical study of terodiline hydrochloride on nervous pollakisuria]. Park YC; Uchida A; Ohnishi N; Kiwamoto H; Esa A; Sugiyama T; Kaneko S; Kurita T Hinyokika Kiyo; 1989 Mar; 35(3):537-40. PubMed ID: 2735258 [TBL] [Abstract][Full Text] [Related]
36. Role of Urodynamic Study in Nocturnal Enuresis: Urodynamic Findings and Treatment Outcome Correlation in Children with Pharmacotherapy-resistant Monosymptomatic Nocturnal Enuresis or Severe Non-monosymptomatic Nocturnal Enuresis. Ryu DS; Lee HW; Kwak KW; Park KH; Baek M Low Urin Tract Symptoms; 2014 May; 6(2):88-93. PubMed ID: 26663546 [TBL] [Abstract][Full Text] [Related]
37. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence. Thomas SH; Higham PD; Hartigan-Go K; Kamali F; Wood P; Campbell RW; Ford GA Br Heart J; 1995 Jul; 74(1):53-6. PubMed ID: 7662454 [TBL] [Abstract][Full Text] [Related]
38. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial. Peters D Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of NS-21, a novel drug for urinary incontinence, and its active metabolite, RCC-36, on L-type calcium currents in isolated guinea pig detrusor smooth muscle cells. Hayashi S; Natsukawa T; Ukai Y; Yoshikuni Y; Kimura K Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):659-66. PubMed ID: 9151307 [TBL] [Abstract][Full Text] [Related]
40. [Therapy of enuresis with a pediatric tablet of propiverin (Mictonettes)]. Nentwich HJ Kinderarztl Prax; 1986 Jun; 54(6):329-33. PubMed ID: 3528628 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]